Cardiac Arrhythmia Mechanisms

The programme addresses cardiometabolic disorders, inflammation and ageing, substance use and cardiovascular toxicity from other therapies, and highlights pregnancy and early childhood as developmental periods shaping lifelong arrhythmia susceptibility. Sessions cover the electrophysiological consequences of substance abuse, cardiometabolic disease, the immune system and arrhythmias, paediatric and prenatal electrophysiology, triggers and modulators of arrhythmias, medical therapies and rhythm disturbances, heart failure, preventive approaches and novel therapies, alongside emerging technologies such as artificial intelligence, digital diagnostics, wearables and implantable loop recorders. The five-day meeting combines talks on unpublished work with extended discussion, poster sessions open to all career stages, and communal meals and free afternoons for informal exchange; attendance is by application.